Literature DB >> 33200197

Genomic profiling of multifocal intrahepatic cholangiocarcinoma reveals intraindividual concordance of genetic alterations.

Sung Hwan Lee1, Eve B Simoneau2, Tatiana Karpinets3, P Andrew Futreal3, Jianjun Zhang4, Milind Javle5, Jianhua Zhang3, Jean-Nicolas Vauthey2, Ju-Seog Lee6, Jeannelyn S Estrella7, Yun Shin Chun2.   

Abstract

In multifocal intrahepatic cholangiocarcinoma (IHC), intrahepatic metastases (IM) represent a contraindication to surgical resection, whereas satellite nodules (SN) do not. However, no consensus criteria exist to distinguish IM from SN. The purpose of this study was to determine genetic alterations and clonal relationships in surgically resected multifocal IHC. Next-generation sequencing of 34 spatially separated IHC tumors was performed using a targeted panel of 201 cancer-associated genes. Proposed definitions in the literature were applied of SN located in the same liver segment and ≤2 cm from the primary tumor; and IM located in a different liver segment and/or >2 cm from the primary tumor. Somatic point mutations concordant across tumors from individual patients included BAP1, SMARCA4 and IDH1. Small insertions and deletions (indels) present at the same genome positions among all tumors from individuals included indels in DNA repair genes, CHEK1, ERCC5, ATR and MSH6. Copy number alterations were also similar between all tumors in each patient. In this cohort of multifocal IHC, genomic profiles were concordant across all tumors in each patient, suggesting a common progenitor cell origin, regardless of the location of tumors in the liver. The decision to perform surgery should not be based upon a perceived distinction between IM and SN.
© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33200197      PMCID: PMC8052956          DOI: 10.1093/carcin/bgaa124

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  23 in total

1.  Intrahepatic cholangiocarcinoma: expert consensus statement.

Authors:  Sharon M Weber; Dario Ribero; Eileen M O'Reilly; Norihiro Kokudo; Masaru Miyazaki; Timothy M Pawlik
Journal:  HPB (Oxford)       Date:  2015-08       Impact factor: 3.647

2.  Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention.

Authors:  Maeve A Lowery; Ryan Ptashkin; Emmet Jordan; Michael F Berger; Ahmet Zehir; Marinela Capanu; Nancy E Kemeny; Eileen M O'Reilly; Imane El-Dika; William R Jarnagin; James J Harding; Michael I D'Angelica; Andrea Cercek; Jaclyn F Hechtman; David B Solit; Nikolaus Schultz; David M Hyman; David S Klimstra; Leonard B Saltz; Ghassan K Abou-Alfa
Journal:  Clin Cancer Res       Date:  2018-05-30       Impact factor: 12.531

3.  Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma.

Authors:  John Bridgewater; Peter R Galle; Shahid A Khan; Josep M Llovet; Joong-Won Park; Tushar Patel; Timothy M Pawlik; Gregory J Gores
Journal:  J Hepatol       Date:  2014-03-27       Impact factor: 25.083

4.  Clinical actionability enhanced through deep targeted sequencing of solid tumors.

Authors:  Ken Chen; Funda Meric-Bernstam; Hao Zhao; Qingxiu Zhang; Nader Ezzeddine; Lin-Ya Tang; Yuan Qi; Yong Mao; Tenghui Chen; Zechen Chong; Wanding Zhou; Xiaofeng Zheng; Amber Johnson; Kenneth D Aldape; Mark J Routbort; Rajyalakshmi Luthra; Scott Kopetz; Michael A Davies; John de Groot; Stacy Moulder; Ravi Vinod; Carol J Farhangfar; Kenna Mills Shaw; John Mendelsohn; Gordon B Mills; Agda Karina Eterovic
Journal:  Clin Chem       Date:  2015-01-27       Impact factor: 8.327

5.  Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis.

Authors:  Samra Turajlic; Kevin Litchfield; Hang Xu; Rachel Rosenthal; Nicholas McGranahan; James L Reading; Yien Ning S Wong; Andrew Rowan; Nnennaya Kanu; Maise Al Bakir; Tim Chambers; Roberto Salgado; Peter Savas; Sherene Loi; Nicolai J Birkbak; Laurent Sansregret; Martin Gore; James Larkin; Sergio A Quezada; Charles Swanton
Journal:  Lancet Oncol       Date:  2017-07-07       Impact factor: 41.316

Review 6.  New Horizons for Precision Medicine in Biliary Tract Cancers.

Authors:  Juan W Valle; Angela Lamarca; Lipika Goyal; Jorge Barriuso; Andrew X Zhu
Journal:  Cancer Discov       Date:  2017-08-17       Impact factor: 39.397

7.  Prognostic Impact of Tumor Multinodularity in Intrahepatic Cholangiocarcinoma.

Authors:  Pietro Addeo; Issam Jedidi; Andrea Locicero; François Faitot; Constantin Oncioiu; Alina Onea; Philippe Bachellier
Journal:  J Gastrointest Surg       Date:  2018-11-26       Impact factor: 3.452

8.  Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles.

Authors:  Farshad Farshidfar; Siyuan Zheng; Marie-Claude Gingras; Yulia Newton; Juliann Shih; A Gordon Robertson; Toshinori Hinoue; Katherine A Hoadley; Ewan A Gibb; Jason Roszik; Kyle R Covington; Chia-Chin Wu; Eve Shinbrot; Nicolas Stransky; Apurva Hegde; Ju Dong Yang; Ed Reznik; Sara Sadeghi; Chandra Sekhar Pedamallu; Akinyemi I Ojesina; Julian M Hess; J Todd Auman; Suhn K Rhie; Reanne Bowlby; Mitesh J Borad; Andrew X Zhu; Josh M Stuart; Chris Sander; Rehan Akbani; Andrew D Cherniack; Vikram Deshpande; Taofic Mounajjed; Wai Chin Foo; Michael S Torbenson; David E Kleiner; Peter W Laird; David A Wheeler; Autumn J McRee; Oliver F Bathe; Jesper B Andersen; Nabeel Bardeesy; Lewis R Roberts; Lawrence N Kwong
Journal:  Cell Rep       Date:  2017-06-27       Impact factor: 9.423

9.  Polyclonal Secondary FGFR2 Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion-Positive Cholangiocarcinoma.

Authors:  Lipika Goyal; Supriya K Saha; Leah Y Liu; Giulia Siravegna; Ignaty Leshchiner; Leanne G Ahronian; Jochen K Lennerz; Phuong Vu; Vikram Deshpande; Avinash Kambadakone; Benedetta Mussolin; Stephanie Reyes; Laura Henderson; Jiaoyuan Elisabeth Sun; Emily E Van Seventer; Joseph M Gurski; Sabrina Baltschukat; Barbara Schacher-Engstler; Louise Barys; Christelle Stamm; Pascal Furet; David P Ryan; James R Stone; A John Iafrate; Gad Getz; Diana Graus Porta; Ralph Tiedt; Alberto Bardelli; Dejan Juric; Ryan B Corcoran; Nabeel Bardeesy; Andrew X Zhu
Journal:  Cancer Discov       Date:  2016-12-29       Impact factor: 39.397

Review 10.  Molecular Pathogenesis and Targeted Therapies for Intrahepatic Cholangiocarcinoma.

Authors:  Agrin Moeini; Daniela Sia; Nabeel Bardeesy; Vincenzo Mazzaferro; Josep M Llovet
Journal:  Clin Cancer Res       Date:  2015-09-24       Impact factor: 12.531

View more
  3 in total

Review 1.  Current challenges to underpinning the genetic basis for cholangiocarcinoma.

Authors:  Antonio Cigliano; Xin Chen; Diego F Calvisi
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2021-04-23       Impact factor: 3.869

Review 2.  Intrahepatic cholangiocarcinoma: Tumour heterogeneity and its clinical relevance.

Authors:  Mina Komuta
Journal:  Clin Mol Hepatol       Date:  2022-01-14

3.  Suppressive effects of umbilical cord mesenchymal stem cell-derived exosomal miR-15a-5p on the progression of cholangiocarcinoma by inhibiting CHEK1 expression.

Authors:  Nuo Li; Baoming Wang
Journal:  Cell Death Discov       Date:  2022-04-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.